Key Insights

Highlights

Treatment Research

5 treatments under study, led by Cisplatin

Research Leaders

5 sponsors active, led by University of Stellenbosch

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03834571Phase 2Withdrawn

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Showing all 1 trials

Research Network

Common Treatments

  • Cisplatin1
  • Patient Monitoring1
  • Carboplatin1
  • Radiation Therapy1
  • Paclitaxel1

Active Sponsors

  • University of Stellenbosch1
  • National Cancer Institute (NCI)1
  • The Emmes Company, LLC1
  • AIDS Malignancy Consortium1
  • University of Arkansas1

Top Investigators

Related Conditions

  • Figo Stage Iii Cervix Carcinoma1
  • Cervical Adenocarcinoma1
  • Cervical Adenosquamous Carcinoma1
  • Cervical Squamous Cell Carcinoma Not Otherwise Specified1
  • Figo Stage Iib Cervix Carcinoma1

Activity Timeline